Reported or proposed issue Pregnancy, breastfeeding, children, liver disease, or cancer history Evidence source No direct human safety data Known or theoretical
Learn what you can expect to pay, common side effects, and how to improve your insurance coverage
These studies reveal that islet-derived proglucagon products are the predominant ligand for beta-cell glucagon-like peptide 1 receptor (GLP-1R) activation and are necessary for the glucoregulatory improvements of DPP-IV inhibitors (DPP-IVi) and vertical sleeve gastrectomy (VSG) (37, 38)
Quick Facts Brand Name: Ozempic Drug Used For: Type-2 Diabetes and off-label weight loss Active Ingredient: Semaglutide Manufacturers With Lawsuits: Novo Nordisk Potential Severe Complications: Stomach paralysis, bowel obstruction, blood clots, vision loss Lawsuit Type: Multidistrict litigation Lawsuit Status: Active Ozempic Lawsuit July 2026 Update Individuals are filing Ozempic lawsuits against Novo Nordisk, alleging a range of injuries, including varied gastrointestinal injuries, vision loss, and pulmonary embolisms